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Abstract 
Background: Toxoplasmosis is a widely distributed zoonotic disease, caused by the protozoan parasite Toxoplasma 
gondii. T. Infections can result in stillbirths, abortions or congenital defects during pregnancy, as well as toxoplasmic 
encephalitis in HIV/AIDS patients. This study aimed to determine the seroprevalence and risk factors for T. gondii infec-
tion in women seeking antenatal and medical care in the locality of Njinikom, North West of Cameroon.
Methods: We conducted a cross-sectional study from August to December 2014 consecutively enrolling 178 con-
senting women aged 15 to 49 years attending antenatal care or medical check-ups at the hospital. A questionnaire 
survey was administered to study participants and potential risk factors for Toxoplasma exposure sought. Venous 
blood was collected and serum from each participant analysed for T. gondii infection as evidenced by the presence 
of anti-T. gondii IgG and IgM antibodies detected using the indirect enzyme-linked immunosorbent assay (ELISA) 
technique. The proportion of anti-T. gondii antibody positivity calculated as the percentage of antibody seropositivity 
to T. gondii antigens. Predictors of T. gondii infection were analysed by univariate and multivariate regression and asso-
ciation with T. gondii seropositivity assessed. Epi-Info 3.5.4 was used for statistical analyses. A p < 0.05 was considered 
significant for all analyses.
Results: The seroprevalence of anti-T. gondii antibodies (IgM or IgG) were 54.5 % (97/178). Among seropositive 
women, 88.7 % (86/97), 30.9 % (30/97), and 19.6 % (19/97) were respectively seropositive for IgG antibody, IgM anti-
body and both IgM and IgG antibodies. Among the risk factors evaluated, only the consumption of raw or under-
cooked meat (p = 0.02) was observed to be an independent risk factor of T. gondii infection. The consumption of 
unwashed vegetables and fruits was significant (p = 0.01) only with simple logistic regression analysis.
Conclusions: Our findings suggest recent T. gondii exposure is high in our study population, and may constitute a 
significant risk factor for stillbirths, abortions or congenital defects during pregnancy in women attending antenatal 
care, or toxoplasmic encephalitis in those who are immunosuppressed such as in HIV/AIDS. Education and screening 
of HIV-positive individuals and pregnant women for T. gondii infection may be important primary prevention strate-
gies in this population.
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Background
Toxoplasmosis is one of the common worldwide parasitic 
zoonosis, caused by the apicomplexa protozoan Toxo-
plasma gondii [1]. This parasite has cats as the definitive 
host, and warm-blooded animals as intermediate hosts 
[2]. T. gondii infects up to a third of the world’s popula-
tion [3] and is reported to be an opportunistic parasitic 
infection in immune compromised hosts [4]. High preva-
lence of the infection has been reported among pregnant 
women and women of childbearing age from different 
parts of the world [5]. The infection occurs widely, and 
varies depending on social and cultural habits, geo-
graphic factors, climate, and route of transmission. It has 
been reported that the prevalence is higher in warm and 
humid areas [6].
Toxoplasma gondii is transmitted to humans through 
ingestion of oocysts in water, food or soil contaminated 
with cat’s faeces, or by eating raw or undercooked meat 
containing cysts [7–10], and women can transmit the 
infection through the placenta to their unborn foetus. 
Other infectious pathways are blood transfusion, and 
organs transplantation [11].
In the majority of immune competent subjects, the 
infection is asymptomatic [3, 12] and frequently results 
in the chronic persistence of cysts within the host tis-
sues. The cysts normally lie dormant, probably for life 
[12]. But, in immune compromised states such as in HIV 
infections, subjects are at risk of developing acute toxo-
plasmosis due to reactivation of the organism if their 
CD4 cell count decreases below 200  cells/μL [13–15]. 
Moreover, in up to 10 % of HIV-infected immune com-
promised individuals, it causes cervical lymphadenopa-
thy or ocular disease [16]. When the infection occurs in 
pregnant women, it can cause severe disease symptoms 
including toxoplasmic encephalitis, blindness, foetal 
abnormalities, abortion and even stillbirth [3, 17]. Toxo-
plasmosis has also been proven to be the cause of abor-
tion and infertility in women [18].
In Cameroon, the few studies on toxoplasma have been 
limited to urban areas. For example, the seroprevalence 
of T. gondii was shown to be high among HIV/AIDS 
patients in the Yaoundé teaching hospital (69.9  %) [19] 
and pregnant women who consulted at the Department 
of Gynaecology in the Douala general hospital (70  %) 
[20]. 71.8 % prevalence was also observed among women 
attending antenatal care in Limbe, along the coastal 
region of Cameroon [21]. The study in Douala observed 
that the consumption of raw vegetables and untreated 
water were the main risk factors associated with toxo-
plasmosis in pregnant women [20].
The aim of this study was therefore to determine the 
seroprevalence of anti-T. gondii antibodies in HIV-
infected and uninfected women of child-bearing age 
attending the antenatal clinic and medical check-ups and 
to identify the risk factors associated with T. gondii infec-




A cross-sectional study was carried out from August to 
December 2014 in St. Martin de Porres Catholic General 
Hospital Njinikom, North West Region of Cameroon.
Study site and population
The St. Martin de Porres Catholic General Hospital 
Njinikom, is a private health care institution run by the 
Sisters of the Franciscan Congregation whose convent 
is located near the hospital. The hospital was created in 
1963. This hospital has an HIV treatment centre, and 
the majority of services rendered are in the domains of 
gynaecology, orthopaedics and general surgery. The 
hospital is situated at about 48 km from Bamenda—the 
regional capital of the North West Region of Cameroon. 
About 75 % of the women in this locality depend on agri-
culture for their livelihoods.
Participants in this study were volunteer women of 
child-bearing age (HIV-infected or uninfected) attend-
ing antenatal or medical check-ups at the hospital and 
who duly provided consent by signing or placing their 
thumbprint on the consent form. Female nurses of 
child-bearing age working in the hospital and other car-
ers of patients at the Hospital were also included in this 
study.
Questionnaire administration and sample collection
Participants of this study were each provided with a 
structured questionnaire to fill. Those who could not read 
were assisted to fill the questionnaires by the laboratory 
technician or antenatal care nurse. The questionnaires 
contained simple closed ended questions regarding 
known risk factors of Toxoplasma exposure in addition 
to socio-demographic information.
Five millilitres of venous blood were collected into two 
tubes pre-labelled with an anonymised patient codes. The 
blood from the EDTA containing tubes was immediately 
tested for the presence of HIV antibodies using Deter-
mine (Alere Determine™ HIV-1/2) test strips according 
to manufacturer’s instructions. The CD4 cell count for 
women who were HIV positive was also measured. The 
second blood sample was allowed to clot completely 
before centrifugation at 3000  rpm for 15  min to obtain 
serum. Serum was separated from the clot into tightly 
screwed microfuge tubes and stored at −20  °C. These 
frozen sera were later tested for the presence of Toxo-
plasma gondii antibodies.
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Serological test for T. gondii antibodies
The presence of T. gondii antibodies in the participants’ 
sera was determined using an indirect Enzyme-Linked 
Immunosorbent Assay (ELISA). This was done using the 
AccuDiag™ Toxo IgM and IgG ELISA Kits (The Diag-
nostic Automation/Cortez Diagnostics, Inc. Toxoplasma 
gondii [Toxo] IgM and IgG Enzyme-Linked Immuno-
sorbent Assay [ELISA]). The Toxo IgM ELISA Kits had 
a specificity of 100  % and a sensitivity of 100  %, while 
the Toxo IgG ELISA Kits had a specificity of 100 % and 
a sensitivity of 95.3 %. Calibrator and controls were run 
with each test assay. The optical densities (OD) obtained 
were used to calculate the cut-off calibrator value and the 
Immune Status Ratio (ISR). The interpretation of results 
was done with respect to the ISR values. For IgM, a sam-
ple with OD ≤ 0.90 was considered negative, OD ≥ 1.10 
was considered positive, and OD =  0.91–1.09 was con-
sidered indeterminate. For IgG, a sample with OD < 0.90 
was considered negative, OD  >  1.10 was considered 
positive, and OD within 0.91–1.09 was considered 
indeterminate.
Ethical consideration
Ethical clearance for this study was obtained from the 
Ethics Review and Consultancy Committee of the Cam-
eroon Bioethics Initiative (CAMBIN) under the reference 
number CBI/283/ERCC/CAMBIN of August 06th, 2014. 
An authorisation to collect and analyse blood samples 
was also obtained from the St. Martin de Porres Catho-
lic Mission Hospital Njinikom. All participants were duly 
informed of the study goals, procedures, potential harm 
and benefits, cost as well as the finality of the study. They 
willingly provided informed consent either by signing 
or placing their thumbprint on the consent form after 
being satisfied with responses to all questions asked the 
investigator. Women less than 21  years provided assent 
and consent from guardian was also sought for these 
women. Information was provided in English, French or 
interpreted in the local dialect by a volunteer independ-
ent of the study team. Participants’ blood samples and 
results were anonymised. Left over blood samples were 
destroyed according to hospital biosafety procedures.
Data management and statistical analysis
Data were entered into Microsoft Excel program and 
then transferred to Epi Info 3.5.4 statistical program. The 
seroprevalence of toxoplasmosis was calculated as the 
proportion of serologically positive anti-T. gondii sam-
ples among all samples tested at 95 % confidence interval 
(CI). A multivariate logistic regression model was used 
to investigate the association between the potential risk 
factors for toxoplasmosis as defined by seropositivity 
for Toxoplasma gondii antibodies of any kind. Variables 
used in the multiple regression were selected through 
step-wise backward elimination using a 20  % cut-off (p 
to remove). The strength of associations was measured 
using the odds ratio (OR) at 95 % CI. The Chi-square test 
was used for group comparisons. Statistical significance 
was set at 5 % and all the associations that showed a p < 
0.05 were considered significant.
Results
A total of 350 eligible women were approached and 
178 women aged 15 to 49  years provided consent for 
this study. The mean age of participating women was 
31.13  ±  8.12  years. The majority of the women were 
aged between 26 and 35  years (70/178, 39.3  %). 53.9  % 
(96/178) of the women were married, and 6.2 % (11/178) 
never went to school. Among the study participants, 
only 5.6 % (10/178) had cats in their homes, while 30.3 % 
(54/178) frequently come in contact with cats because of 
neighbours owning cats. A total of 59.6 % (106/178) con-
sumed raw or undercooked meat. 5.1  % (9/178), 65.7  % 
(117/178), and 73.1  % (130/178) women consumed raw 
milk, raw unwashed vegetable or fruits, and untreated 
drinking water respectively. Regarding the participants 
residential area, 5.1  % (9/178) of the study participants 
lived in an urban area, while 94.9 % (169/178) lived in a 
rural area. Those women who lived in cemented and non-
cemented floor houses were 38.2 % (68/178), and 61.8 % 
(110/178) respectively. Only 1.7  % (3/178) knew about 
toxoplasmosis (Table 1). Out of the 178 women recruited 
in this study, 50.6 % (90/178) were HIV-positive, 49.4 % 
(88/178) were HIV-negative, 50.6 % (90/178) were preg-
nant and 49.4  % (88/178) were not pregnant. Of the 90 
HIV-positive participants only 3.3  % (3/90) had a CD4 
count less than 200  cells/mm3 and 84.5  % (76/90) HIV-
infected participants lived on HAART (Table 1).
Prevalence of anti‑Toxoplasma antibodies in the study 
population
The combined seroprevalence of anti-T. gondii antibod-
ies among the 178 women of child-bearing age in our 
study area was calculated to be 54.5 % (97/178). Among 
the seropositive women, 86 were seropositive for IgG 
antibodies, 30 were seropositive to IgM antibodies, and 
19 were seropositive for both IgG and IgM antibodies 
giving a prevalence of 48.3, 16.9 and 10.7 % respectively 
(Table 2).
Table 2 also illustrates that the seroprevalence of anti-
bodies to T. gondii was slightly higher in HIV-negative 
(55.7 %, [49/88]), than in HIV-positive (53.7 % [48/90]) 
participants (p > 0.05). Seroprevalence of anti-T. gondii 
IgG antibody was 47.8  % (43/90) in HIV-positive par-
ticipants, and slightly lower than in HIV-negative par-
ticipants (48.9  %, [43/88]). On the other hand, 12.2  % 
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(11/90) of HIV-positive against 9.1  % (8/88) of HIV-
negative women were seropositive to both IgG and IgM 
antibodies to T. gondii. Similarly, a higher seropreva-
lence of IgM antibody to T. gondii was found in HIV-
positive (17.8 %, [16/90]), than in HIV-negative (15.9 %, 
[14/88]) women. A total of 55.7 % (49/88) non-pregnant 
women were seropositive to anti-T. gondii antibodies. 
This was slightly higher than the 53.3  % (48/90) preg-
nant women also seropositive to anti-T. gondii antibod-
ies (Table 2).
Risk factors for Toxoplasma seropositivity
As shown in Table 3, simple logistic regression analysis 
with suspected variable indicated that the consump-
tion of raw or undercooked meat (p  =  0.01) and the 
consumption of raw unwashed vegetables and fruits 
(p = 0.01) were predictors of toxoplasmosis seropositiv-
ity irrespective of the antibody type. However, results 
of multiple logistic regression analysis of selected vari-
ables as shown in Table  4 showed that only the con-
sumption of raw or undercooked meat (p =  0.02) was 
an independent predictor of toxoplasmosis seroposi-
tivity irrespective of the antibody type. No significant 
association was found between Toxoplasma gondii 
seropositivity and HIV status (p = 0.18), cat ownership 
(p = 0.91), contact with cats (p = 0.31) and residential 
area (p = 0.16).
Discussion
Toxoplasmosis is a curable but potentially fatal disease 
[22]. Over the years, infection with the protozoan par-
asite Toxoplasma gondii has been proven to be one of 
the most common parasitic infections of man and other 
warm-blooded animals [2]. In this study, we sought to 
investigate Toxoplasma infection, as evidenced by anti-
Toxoplasma antibodies in the serum of women of child 
bearing age in a rural locality in Cameroon. Our find-
ings revealed that the seroprevalence of anti-T. gon-
dii antibodies among the women of child-bearing age 
in this study was 54.5  %. This prevalence was similar 
to that obtained among women of child-bearing age 
in Timis, Romania (57.6  %) [23], but far lower than 
that found in women of child-bearing age in Central 
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Ethiopia (81.4  %) [24]. This lower prevalence could be 
attributed to a lower cat density (10/178, Table  1) and 
consequent oocysts shedding and a lower consumption 
of unpasteurised milk in our study area. The seropreva-
lence obtained in this study is also far lower than that 
obtained in other parts of Cameroon. Indeed, a preva-
lence of 77.1  % was observed in pregnant women in 
Yaoundé [25], 70 % in pregnant women in Douala [20], 
69.9  % in HIV/AIDS patients in Yaoundé [19], while a 
prevalence of 71.8  % was observed among pregnant 
women in Limbe [21]. These geographic differences 
in prevalence rates may be explained by differences in 
rural/urban setting since exposure and the main sources 
of infection appear to be the same. This might explain 
differences in risk factors of Toxoplasma seropositivity 
as well as climatic changes. Our study population was 
mainly from a rural area.
The seroprevalence of anti-T. gondii IgG antibody 
in HIV-positive participants was 47.8  % (43/90). This 
was not significantly different from the 48.9  % (43/88) 
obtained in the HIV-negative group in this same study 
population (X2 = 1.3632, p = 0.1728). This results were 
similar to the 42.1  % (56/133) obtained among HIV/
AIDS patients in the university teaching hospital in 
Yaoundé [19], although the number of HIV patients 
in our study was smaller. Similarity in the prevalence 
of Toxoplasma seropositivity among HIV-infected or 
uninfected women in our study conforms to what has 
been reported by researchers in Malaysia [26], United 
States of America [27], and Ethiopia [28]. However, 
another study in Ethiopia showed a significantly higher 
prevalence of anti-Toxoplasma gondii antibodies (87.4 % 
vs 70.29  %, P  =  0.003) in HIV-positive pre-antiretro-
viral therapy (pre-ART) individuals than in HIV-neg-
ative blood donors [10]. Indeed, in our study, up to 
84.5  % (76/90) of the HIV positive study participants 
were on highly active antiretroviral therapy (HAART), 
and only three participants had CD4 counts less than 
200cells/mm3 of whole blood. This indicate the ben-
efit of HAART treatment which helps to decrease the 
viral load and improve CD4+  cell counts and conse-
quently boosts the immune system of the host, with the 
added benefit of reducing the likelihood of reactiva-
tion of latent T. gondii infections [1, 29, 30]. We found 
a non-significant higher IgM antibodies in HIV positive 
women compared to HIV negative women, further con-
firming this assertion.
The seroprevalence of anti-T. gondii antibodies was 
higher in non-pregnant women (55.7  %, [49/88]) com-
pared to pregnant women (53.3  %, [48/90]) irrespec-
tive of HIV status, although not significantly different. 
Among the 90 pregnant women enrolled in this study, 
48.9 % (44/90) and 13.3 (12/90) were positive for anti-T. 
gondii IgG and IgM antibodies respectively. These preva-
lence values were significantly low compared to 71.8 and 
67.6 % respectively obtain among pregnant women in the 
Limbe health district in the South West Region of Cam-
eroon [21].
The consumption of raw or undercooked meat 
[p  =  0.0184] was significant a risk factor associated 
with T. gondii infection in the univariate and multivari-
ate analysis (Tables 3a and 4). In addition, consumption 
of unwashed vegetables or fruits was observed to be sig-
nificantly associated with toxoplasma seropositivity in 
the univariate analysis, although it was only marginally 
significant in the multivariable analysis Table  4. Similar 
results have been observed in studies done in Mexico 
[31], Ethiopia [10], and Sudan [32], whereas studies done 
in Douala-Cameroon [20], and Thailand [33], showed a 
significant association between T. gondii infection and 
consumption of untreated water only. Although domes-
tic cats are probably the major source of contamination 
[1, 34], cat ownership and contact with cats were not 
found to be significantly associated with T. gondii infec-
tion [9, 13]. Indeed, only 6 % of the total study population 
reported having cats at home. Sporulated oocysts survive 
Table 2 Seroprevalence of antibodies to Toxoplasma gondii according to pregnancy and HIV status
+ Positive: Percentages calculated with respect to totals in each sub category. For example, we found that 41.2 % of women who were HIV positive and pregnant were 
seropositive to IgG antibody to T. gondii
HIV status Pregnant Non pregnant Total Grand total
IgG+ HIV-positive 7/17 (41.2 %) (18.4–67.1) 36/73 (49.3 %) (37.4–61.3) 43/90 (47.8 %) (37.1–58.6) 86/178 (48.3 %) (40.8–55.9)
HIV-negative 37/73 (50.7 %) (38.7–62.6) 6/15 (40 %) (16.3–76.7) 43/88 (48.9 %) (38.1–59.7)
IgM+ HIV-positive 2/17 (11.8 %) (1.6–36.4) 14/73 (19.2 %) (10.9–30.1) 16/90 (17.8 %) (10.5–27.2) 30/178 (16.9 %) (11.7–23.2)
HIV-negative 10/73 (13.7 %) (6.8–23.7) 4/15 (26.7 %) (7.8–55.1) 14/88 (15.9 %) (9.0–25.2)
IgG+ and IgM+ HIV-positive 1/17 (5.9 %) (0.1–28.7) 10/73 (13.7 %) (6.8–23.7) 11/90 (12.2 %) (6.3–20.8) 19/178 (10.7 %) (6.6–16.2)
HIV-negative 7/73 (9.6 %) (3.9–18.8) 1/15 (6.7 %) (0.2–31.9) 8/88 (9.1 %) (4.0–17.1)
IgG+ or IgM+ HIV-positive 8/17 (47.1 %) (22.9–72.2) 40/73 (54.8 %) (1.5–13.4) 48/90 (53.3 %) (42.5–63.9) 97/178 (54.5 %) (46.9–70.0)
HIV-negative 40/73 (54.8 %) (42.7–66.5) 9/15 (60 %) (32.3–83.7) 49/88 (55.7 %) (44.7–66.3)
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in moist soil for months to years [35]. Though no signifi-
cance association was found between T. gondii infection 
and untreated water, it is likely that oocysts might have 
been present in some of the untreated water sources in 
our study area. Poor sanitation methods with the poor 
quality water used to wash raw meat at abattoirs or veg-
etables sold in the market, might have led to their con-
tamination with oocysts.
Our study however should be interpreted with some 
caution. Our sample size was small and conclusions from 
the present study must be measured. It is likely that we 
may obtain different results with increased sample size. 
The number of equivocal results obtained using the 
selected ELISA technique in some cases was high, and 
difficult to interpret with the absence of reference testing 
facilities for toxoplasmosis in or around our study area. 
This could affect our results by increasing or decreas-
ing the observed prevalences. Secondly, we observed an 
increase in risk of seropositivity with stage in pregnancy, 
but we did not follow up those women who were sero-
positive to study delivery outcomes or health status of 
their children. Thirdly, we may have obtained a different 
result if we considered sampling only women of child 
bearing age at the antenatal service. However, less than 
30 % of our study population was sampled among those 
who came for medical check-up at the hospital, mak-
ing our results more likely to reflect what we desired to 
investigate.
Conclusions
Toxoplasma gondii infection appears to be a public 
health concern in Njinikom, with a global antibody sero-
prevalence of 54.5 % among women of child bearing age 
attending antenatal or outpatient medical care in our 
study area. In this study, recent infections were found 
in 16.9 % of the study population while up to 10.7 % of 
patients were reactivating and there was no difference 
between pregnant and non-pregnant or HIV negative 
or HIV positive women. Consumption of raw or under-
cooked meat and of unwashed vegetables were observed 
Table 3 Simple logistic regression with  suspected vari-
ables
* p < 5 %: statistical significance; OR > 1 and OR < 1: association of variable with 
toxoplasmosis
Variable No of subjects tested 
(n,  %), N = 178




15–21 20 (11.2) 1.2
>21 158 (88.8) (0.48–3.11)
Education 0.53
Yes 167 (93.8) 0.67
No 11 (6.2) (0.19–2.37)
Marital status 0.84
Married 96 (53.9) 1.06
Unmarried 82 (46.1) (0.59–1.92)
House floor type 0.79
Cemented 68 (38.2) 1.0848
Not cemented 110 (61.8) (0.5922–1.9873)
Residential area 0.81
Rural 9 (5.1) 1.1782
Urban 169 (94.9) (0.3058–4.5397)
Pregnancy status 0.25
Yes 90 (50.6) 0.8522
No 88 (49.4) (0.6469–1.1225)
HIV status 0.88
Yes 90 (50.6) 0.9574
No 88 (49.4) (0.5318–1.7238)
Cat ownership 0.91
Yes 10 (5.6) 0.9310
No 168 (94.4) (0.2599–3.3352)
Contact with cats 0.31
Yes 54 (30.3) 1.3920
No 124 (69.7) (0.73–2.65)
Consumption of raw or undercooked meat 0.01*
Yes 106 (59.6) 2.18
No 72 (40.4) (1.17–4.02)
Consumption of raw unwashed vegetables or fruits 0.01*
Yes 117 (65.7) 2.08
No 61 (34.3) (1.11–3.89)
Consumption of raw milk 0.81
Yes 9 (5.1) 1.1782
No 169 (94.9) (0.3058–4.5397)
Table 4 Multiple logistic regression of selected variables
* p < 5 %: statistical significance; OR > 1 and OR < 1: association of variable with 
toxoplasmosis
Variables Adjusted odd ratio 
(95 % CI)
p value
HIV status 0.74 (0.40–1.49) 0.18
Yes
No










Residential area 2.90 (0.65–13.0) 0.16
Rural
Urban
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to be risk factors for T. gondii infection among women of 
childbearing age in the locality of Njinikom, North West 
Region of Cameroon. Only 1.7  % (3/178) of the study 
participants knew about toxoplasmosis. Education on 
toxoplasmosis during antenatal care or in HIV treatment 
centres and screening for recent Toxoplasma exposure 
may be strategies for primary prevention of toxoplasmo-
sis and its devastating outcomes in pregnancy or among 
HIV patients.
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